Review



pljm1 flag ragb q99l  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Addgene inc pljm1 flag ragb q99l
    Pljm1 Flag Ragb Q99l, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 19 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pljm1 flag ragb q99l/product/Addgene inc
    Average 92 stars, based on 19 article reviews
    pljm1 flag ragb q99l - by Bioz Stars, 2026-03
    92/100 stars

    Images



    Similar Products

    92
    Addgene inc pljm1 flag ragb q99l
    Pljm1 Flag Ragb Q99l, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pljm1 flag ragb q99l/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    pljm1 flag ragb q99l - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pljm1 flag ragb gtp q99l mutant plasmid
    KEY RESOURCES TABLE
    Pljm1 Flag Ragb Gtp Q99l Mutant Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pljm1 flag ragb gtp q99l mutant plasmid/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    pljm1 flag ragb gtp q99l mutant plasmid - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    92
    Addgene inc pljm1 flag ragb gtp q99l
    KEY RESOURCES TABLE
    Pljm1 Flag Ragb Gtp Q99l, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pljm1 flag ragb gtp q99l/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    pljm1 flag ragb gtp q99l - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    92
    Addgene inc ragb q99l
    PLX4720 promotes TFEB activation through ERK inhibition. a Confocal analyses of the subcellular distribution of endogenous TFEB, TFE3, and MITF in A375 cells treated with DMSO or PLX4720 (1 μM, 12 h). Nuclei were stained with DAPI (blue). n = 3 independent experiments. b Quantification of nuclear translocation of TFEB, TFE3, and MITF in cells in ( a ). n = 150 cells, pooled from three independent experiments. c Immunoblots for TFEB, MITF, and TFEB3 in the cytoplasmic/nuclear fractions of A375 cells treated with PLX4720 (1 μM, 12 h). Lamin B1 is the control for the nuclear fractions, whereas LAMP1 and Tubulin are the controls for the cytoplasmic fractions. d Immunoblotting of endogenous TFEB and p-14-3-3-binding motif of TFEB from PLX4720 (1 μM, 12 h-treated) A375 cells. WCL whole-cell lysate. e PLX4720 disrupts TFEB interaction with 14-3-3. WCLs of A375 cells were immunoprecipitated (IP) with anti-TFEB, followed by immunoblotting (IB) with antibodies against 14-3-3 and TFEB. f Representative images (top) and quantification (middle) of nuclear translocation of TFEB in A375 cells stably expressing mTORC1 (E2419K), <t>RagB</t> GTPase <t>(Q99L),</t> or ERK (R67S/D321N), or DEPDC5-specific shRNA, with or without the treatment of PLX4720 (1 μM, 12 h), or ERK inhibitor FR180204 (ERKi, 10 μM, 24 h). IB showed protein expression as indicated with the corresponding mTORC1 activity (p-p70S6K and p-4E-BP1). n = 4 independent experiments. g Representative confocal images (top) and quantification (bottom) of nuclear localization of endogenous TFEB in A375 and MeWo cells treated with FR180204 or with ERK shRNA. n = 4 independent experiments. h Immunoblots for endogenous TFEB, TFE3, MITF, and ERK in cytoplasmic/nuclear fractions of A375 cells treated with DMSO or FR180204 (10 μM, 24 h) or with ERK shRNA. Scale bars, 10 μm. Data in c , d , e , f , and h are from one experiment that is representative of three independent experiments. For all quantification, data represent the mean ± SD derived from the indicated number of independent experiments. Comparisons were made using Student’s t -test. *** P < 0.001; n.s. not significant. See Supplementary Fig. for uncropped data of c , e , f , h
    Ragb Q99l, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ragb q99l/product/Addgene inc
    Average 92 stars, based on 1 article reviews
    ragb q99l - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    90
    Addgene inc flag pljm1 ragb q99l plasmid #19315
    PLX4720 promotes TFEB activation through ERK inhibition. a Confocal analyses of the subcellular distribution of endogenous TFEB, TFE3, and MITF in A375 cells treated with DMSO or PLX4720 (1 μM, 12 h). Nuclei were stained with DAPI (blue). n = 3 independent experiments. b Quantification of nuclear translocation of TFEB, TFE3, and MITF in cells in ( a ). n = 150 cells, pooled from three independent experiments. c Immunoblots for TFEB, MITF, and TFEB3 in the cytoplasmic/nuclear fractions of A375 cells treated with PLX4720 (1 μM, 12 h). Lamin B1 is the control for the nuclear fractions, whereas LAMP1 and Tubulin are the controls for the cytoplasmic fractions. d Immunoblotting of endogenous TFEB and p-14-3-3-binding motif of TFEB from PLX4720 (1 μM, 12 h-treated) A375 cells. WCL whole-cell lysate. e PLX4720 disrupts TFEB interaction with 14-3-3. WCLs of A375 cells were immunoprecipitated (IP) with anti-TFEB, followed by immunoblotting (IB) with antibodies against 14-3-3 and TFEB. f Representative images (top) and quantification (middle) of nuclear translocation of TFEB in A375 cells stably expressing mTORC1 (E2419K), <t>RagB</t> GTPase <t>(Q99L),</t> or ERK (R67S/D321N), or DEPDC5-specific shRNA, with or without the treatment of PLX4720 (1 μM, 12 h), or ERK inhibitor FR180204 (ERKi, 10 μM, 24 h). IB showed protein expression as indicated with the corresponding mTORC1 activity (p-p70S6K and p-4E-BP1). n = 4 independent experiments. g Representative confocal images (top) and quantification (bottom) of nuclear localization of endogenous TFEB in A375 and MeWo cells treated with FR180204 or with ERK shRNA. n = 4 independent experiments. h Immunoblots for endogenous TFEB, TFE3, MITF, and ERK in cytoplasmic/nuclear fractions of A375 cells treated with DMSO or FR180204 (10 μM, 24 h) or with ERK shRNA. Scale bars, 10 μm. Data in c , d , e , f , and h are from one experiment that is representative of three independent experiments. For all quantification, data represent the mean ± SD derived from the indicated number of independent experiments. Comparisons were made using Student’s t -test. *** P < 0.001; n.s. not significant. See Supplementary Fig. for uncropped data of c , e , f , h
    Flag Pljm1 Ragb Q99l Plasmid #19315, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flag pljm1 ragb q99l plasmid #19315/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    flag pljm1 ragb q99l plasmid #19315 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Addgene inc pljm1-flag-ragb-q99l #19315
    PLX4720 promotes TFEB activation through ERK inhibition. a Confocal analyses of the subcellular distribution of endogenous TFEB, TFE3, and MITF in A375 cells treated with DMSO or PLX4720 (1 μM, 12 h). Nuclei were stained with DAPI (blue). n = 3 independent experiments. b Quantification of nuclear translocation of TFEB, TFE3, and MITF in cells in ( a ). n = 150 cells, pooled from three independent experiments. c Immunoblots for TFEB, MITF, and TFEB3 in the cytoplasmic/nuclear fractions of A375 cells treated with PLX4720 (1 μM, 12 h). Lamin B1 is the control for the nuclear fractions, whereas LAMP1 and Tubulin are the controls for the cytoplasmic fractions. d Immunoblotting of endogenous TFEB and p-14-3-3-binding motif of TFEB from PLX4720 (1 μM, 12 h-treated) A375 cells. WCL whole-cell lysate. e PLX4720 disrupts TFEB interaction with 14-3-3. WCLs of A375 cells were immunoprecipitated (IP) with anti-TFEB, followed by immunoblotting (IB) with antibodies against 14-3-3 and TFEB. f Representative images (top) and quantification (middle) of nuclear translocation of TFEB in A375 cells stably expressing mTORC1 (E2419K), <t>RagB</t> GTPase <t>(Q99L),</t> or ERK (R67S/D321N), or DEPDC5-specific shRNA, with or without the treatment of PLX4720 (1 μM, 12 h), or ERK inhibitor FR180204 (ERKi, 10 μM, 24 h). IB showed protein expression as indicated with the corresponding mTORC1 activity (p-p70S6K and p-4E-BP1). n = 4 independent experiments. g Representative confocal images (top) and quantification (bottom) of nuclear localization of endogenous TFEB in A375 and MeWo cells treated with FR180204 or with ERK shRNA. n = 4 independent experiments. h Immunoblots for endogenous TFEB, TFE3, MITF, and ERK in cytoplasmic/nuclear fractions of A375 cells treated with DMSO or FR180204 (10 μM, 24 h) or with ERK shRNA. Scale bars, 10 μm. Data in c , d , e , f , and h are from one experiment that is representative of three independent experiments. For all quantification, data represent the mean ± SD derived from the indicated number of independent experiments. Comparisons were made using Student’s t -test. *** P < 0.001; n.s. not significant. See Supplementary Fig. for uncropped data of c , e , f , h
    Pljm1 Flag Ragb Q99l #19315, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pljm1-flag-ragb-q99l #19315/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    pljm1-flag-ragb-q99l #19315 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Addgene inc flag ragb q99l
    PLX4720 promotes TFEB activation through ERK inhibition. a Confocal analyses of the subcellular distribution of endogenous TFEB, TFE3, and MITF in A375 cells treated with DMSO or PLX4720 (1 μM, 12 h). Nuclei were stained with DAPI (blue). n = 3 independent experiments. b Quantification of nuclear translocation of TFEB, TFE3, and MITF in cells in ( a ). n = 150 cells, pooled from three independent experiments. c Immunoblots for TFEB, MITF, and TFEB3 in the cytoplasmic/nuclear fractions of A375 cells treated with PLX4720 (1 μM, 12 h). Lamin B1 is the control for the nuclear fractions, whereas LAMP1 and Tubulin are the controls for the cytoplasmic fractions. d Immunoblotting of endogenous TFEB and p-14-3-3-binding motif of TFEB from PLX4720 (1 μM, 12 h-treated) A375 cells. WCL whole-cell lysate. e PLX4720 disrupts TFEB interaction with 14-3-3. WCLs of A375 cells were immunoprecipitated (IP) with anti-TFEB, followed by immunoblotting (IB) with antibodies against 14-3-3 and TFEB. f Representative images (top) and quantification (middle) of nuclear translocation of TFEB in A375 cells stably expressing mTORC1 (E2419K), <t>RagB</t> GTPase <t>(Q99L),</t> or ERK (R67S/D321N), or DEPDC5-specific shRNA, with or without the treatment of PLX4720 (1 μM, 12 h), or ERK inhibitor FR180204 (ERKi, 10 μM, 24 h). IB showed protein expression as indicated with the corresponding mTORC1 activity (p-p70S6K and p-4E-BP1). n = 4 independent experiments. g Representative confocal images (top) and quantification (bottom) of nuclear localization of endogenous TFEB in A375 and MeWo cells treated with FR180204 or with ERK shRNA. n = 4 independent experiments. h Immunoblots for endogenous TFEB, TFE3, MITF, and ERK in cytoplasmic/nuclear fractions of A375 cells treated with DMSO or FR180204 (10 μM, 24 h) or with ERK shRNA. Scale bars, 10 μm. Data in c , d , e , f , and h are from one experiment that is representative of three independent experiments. For all quantification, data represent the mean ± SD derived from the indicated number of independent experiments. Comparisons were made using Student’s t -test. *** P < 0.001; n.s. not significant. See Supplementary Fig. for uncropped data of c , e , f , h
    Flag Ragb Q99l, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flag ragb q99l/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    flag ragb q99l - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    KEY RESOURCES TABLE

    Journal: Cell metabolism

    Article Title: Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity

    doi: 10.1016/j.cmet.2018.04.009

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: The ARG2 (H160F) mutant was generated using Stratagene’s QuikChange II mutagenesis kit (Agilent). pLJM1-Flag-RagB GTP -Q99L mutant plasmid was obtained from Addgene (plasmid no. 19315) and subcloned into pCDH-CMV-MCS-Neomycin (System Biosciences).

    Techniques: Recombinant, Arginase Activity Assay, Colorimetric Assay, Mutagenesis, Software

    KEY RESOURCES TABLE

    Journal: Cell metabolism

    Article Title: Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity

    doi: 10.1016/j.cmet.2018.04.009

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: pLJM1-Flag-RagB GTP -Q99L , Addgene , 19315.

    Techniques: Recombinant, Multiplex sample analysis, Arginase Activity Assay, Colorimetric Assay, Mutagenesis, Software

    PLX4720 promotes TFEB activation through ERK inhibition. a Confocal analyses of the subcellular distribution of endogenous TFEB, TFE3, and MITF in A375 cells treated with DMSO or PLX4720 (1 μM, 12 h). Nuclei were stained with DAPI (blue). n = 3 independent experiments. b Quantification of nuclear translocation of TFEB, TFE3, and MITF in cells in ( a ). n = 150 cells, pooled from three independent experiments. c Immunoblots for TFEB, MITF, and TFEB3 in the cytoplasmic/nuclear fractions of A375 cells treated with PLX4720 (1 μM, 12 h). Lamin B1 is the control for the nuclear fractions, whereas LAMP1 and Tubulin are the controls for the cytoplasmic fractions. d Immunoblotting of endogenous TFEB and p-14-3-3-binding motif of TFEB from PLX4720 (1 μM, 12 h-treated) A375 cells. WCL whole-cell lysate. e PLX4720 disrupts TFEB interaction with 14-3-3. WCLs of A375 cells were immunoprecipitated (IP) with anti-TFEB, followed by immunoblotting (IB) with antibodies against 14-3-3 and TFEB. f Representative images (top) and quantification (middle) of nuclear translocation of TFEB in A375 cells stably expressing mTORC1 (E2419K), RagB GTPase (Q99L), or ERK (R67S/D321N), or DEPDC5-specific shRNA, with or without the treatment of PLX4720 (1 μM, 12 h), or ERK inhibitor FR180204 (ERKi, 10 μM, 24 h). IB showed protein expression as indicated with the corresponding mTORC1 activity (p-p70S6K and p-4E-BP1). n = 4 independent experiments. g Representative confocal images (top) and quantification (bottom) of nuclear localization of endogenous TFEB in A375 and MeWo cells treated with FR180204 or with ERK shRNA. n = 4 independent experiments. h Immunoblots for endogenous TFEB, TFE3, MITF, and ERK in cytoplasmic/nuclear fractions of A375 cells treated with DMSO or FR180204 (10 μM, 24 h) or with ERK shRNA. Scale bars, 10 μm. Data in c , d , e , f , and h are from one experiment that is representative of three independent experiments. For all quantification, data represent the mean ± SD derived from the indicated number of independent experiments. Comparisons were made using Student’s t -test. *** P < 0.001; n.s. not significant. See Supplementary Fig. for uncropped data of c , e , f , h

    Journal: Nature Communications

    Article Title: Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance

    doi: 10.1038/s41467-019-09634-8

    Figure Lengend Snippet: PLX4720 promotes TFEB activation through ERK inhibition. a Confocal analyses of the subcellular distribution of endogenous TFEB, TFE3, and MITF in A375 cells treated with DMSO or PLX4720 (1 μM, 12 h). Nuclei were stained with DAPI (blue). n = 3 independent experiments. b Quantification of nuclear translocation of TFEB, TFE3, and MITF in cells in ( a ). n = 150 cells, pooled from three independent experiments. c Immunoblots for TFEB, MITF, and TFEB3 in the cytoplasmic/nuclear fractions of A375 cells treated with PLX4720 (1 μM, 12 h). Lamin B1 is the control for the nuclear fractions, whereas LAMP1 and Tubulin are the controls for the cytoplasmic fractions. d Immunoblotting of endogenous TFEB and p-14-3-3-binding motif of TFEB from PLX4720 (1 μM, 12 h-treated) A375 cells. WCL whole-cell lysate. e PLX4720 disrupts TFEB interaction with 14-3-3. WCLs of A375 cells were immunoprecipitated (IP) with anti-TFEB, followed by immunoblotting (IB) with antibodies against 14-3-3 and TFEB. f Representative images (top) and quantification (middle) of nuclear translocation of TFEB in A375 cells stably expressing mTORC1 (E2419K), RagB GTPase (Q99L), or ERK (R67S/D321N), or DEPDC5-specific shRNA, with or without the treatment of PLX4720 (1 μM, 12 h), or ERK inhibitor FR180204 (ERKi, 10 μM, 24 h). IB showed protein expression as indicated with the corresponding mTORC1 activity (p-p70S6K and p-4E-BP1). n = 4 independent experiments. g Representative confocal images (top) and quantification (bottom) of nuclear localization of endogenous TFEB in A375 and MeWo cells treated with FR180204 or with ERK shRNA. n = 4 independent experiments. h Immunoblots for endogenous TFEB, TFE3, MITF, and ERK in cytoplasmic/nuclear fractions of A375 cells treated with DMSO or FR180204 (10 μM, 24 h) or with ERK shRNA. Scale bars, 10 μm. Data in c , d , e , f , and h are from one experiment that is representative of three independent experiments. For all quantification, data represent the mean ± SD derived from the indicated number of independent experiments. Comparisons were made using Student’s t -test. *** P < 0.001; n.s. not significant. See Supplementary Fig. for uncropped data of c , e , f , h

    Article Snippet: The full-length complementary DNA (cDNA) clones of human TFEB (plasmid #99955), BRAF V600E (plasmid #15269), mTOR (E2419K) (plasmid #19994), ERK (R67S/D321N) (plasmid #53203), and RagB (Q99L) (plasmid #19315), were purchased from Addgene (USA).

    Techniques: Activation Assay, Inhibition, Staining, Translocation Assay, Western Blot, Control, Binding Assay, Immunoprecipitation, Stable Transfection, Expressing, shRNA, Activity Assay, Derivative Assay